| Journal Profile | |
| Journal Title | Molecular Cancer
|
| Journal Title Abbreviations | MOL CANCER |
| ISSN | 1476-4598 |
| h-index | 103 |
| CiteScore | | CiteScore | SJR | SNIP | CiteScore Rank |
|---|
| 19.00 | 4.581 | 2.969 | | Subject field | Quartiles | Rank | Percentile | Category: Medicine
Subcategory: Oncology | Q1 | 10 / 331 |
| Category: Medicine
Subcategory: Molecular Medicine | Q1 | 4 / 165 |
| Category: Medicine
Subcategory: Cancer Research | Q1 | 6 / 198 |
|
|
|
| Self-Citation Ratio (2019-2020) | 2.90% |
| Official Website | https://www.springer.com/journal/12943 |
| Online Manuscript Submission | https://www.editorialmanager.com/MOLC |
| Open Access | Yes |
| Publisher | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL |
| Subject Area | Medicine |
| Country/Area of Publication | ENGLAND |
| Publication Frequency | Monthly |
| Year Publication Started | 2002 |
| Annual Article Volume | 175 |
| Indexing (SCI or SCIE) | Science Citation Index Expanded
|
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D |
| Average Duration of Peer Review * | Authorized Data from Publisher:
Data from Authors: Average 2 Month(s) |
| Competitiveness * | Data from Authors: About 50% |
| Useful Links | |
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |
